Natural Rubber Latex Allergy
Natural rubber latex allergy (NRLA) is an allergic condition caused by proteins found in natural rubber latex, which is obtained from the rubber tree Hevea brasiliensis. It is particularly important among healthcare workers, people with an atopic background, individuals with certain congenital conditions, and others who have frequent exposure to latex products.
What Is Natural Rubber Latex Allergy?
Latex contains several proteins that can trigger allergic reactions. Repeated exposure, especially in healthcare and occupational settings, can increase the risk of sensitization.
People at higher risk include:
- Healthcare professionals and hospital workers
- Food handlers and domestic workers
- Hairdressers and rubber industry workers
- Construction workers, painters and florists
- Security personnel and firefighters
- Individuals with spina bifida and certain congenital abnormalities
- People with an atopic constitution
Latex allergy may also occur through exposure to products such as gloves, catheters, balloons, elastic bands, condoms, masks and other medical or household items.
Clinical Features of Latex Allergy
The severity of a latex reaction depends on the route, concentration and duration of exposure, as well as the individual’s susceptibility.
Immediate IgE-Mediated Reactions
These reactions can occur soon after exposure and may cause:
- Itching and hives (urticaria)
- Swelling (angioedema)
- Runny nose and conjunctivitis
- Wheezing or asthma symptoms
- Anaphylaxis in severe cases
Healthcare procedures such as surgery, dental treatment or catheterization can sometimes result in significant exposure.
Latex-Fruit Syndrome
Some people with latex allergy may also react to certain fruits and vegetables because of cross-reactive proteins. Commonly associated foods include:
- Banana
- Avocado
- Kiwi
- Chestnut
- Potato
- Tomato
- Bell pepper
Food reactions should be assessed individually rather than assuming that every person with latex allergy must avoid these foods.
Delayed Allergic Contact Dermatitis
This is a delayed skin reaction that may develop 48–72 hours after exposure. It can cause redness, itching, dryness and irritation. It is often related to chemicals or additives used during rubber processing rather than the latex proteins themselves.
Irritant Dermatitis
Some people develop localized dryness, redness and itching after contact with latex products without having an immune-mediated latex allergy.
How Is Latex Allergy Diagnosed?
Diagnosis begins with a detailed medical and occupational history, followed by appropriate allergy testing.
Skin Prick Test
A skin prick test using a latex allergen extract may be used as an initial investigation for immediate allergic reactions.
Blood Tests
Latex-specific IgE testing can help identify sensitization to latex. However, the results need to be interpreted together with the patient’s symptoms and clinical history.
Component-Resolved Diagnosis
Component-resolved diagnosis (CRD) can identify sensitization to individual latex proteins such as Hev b 1, Hev b 3, Hev b 5, Hev b 6 and others. This can help doctors better understand the pattern and possible clinical relevance of sensitization.
Patch Testing
Patch testing may be useful when delayed allergic contact dermatitis caused by rubber additives is suspected.
Basophil Activation Test
The basophil activation test (BAT) measures the response of basophils to specific latex allergens and may help distinguish clinically relevant sensitization from asymptomatic sensitization.
Challenge Tests
In selected cases, supervised challenge procedures such as glove-use or respiratory provocation tests may be considered. These tests should only be performed under appropriate specialist supervision because latex exposure can cause significant reactions.
Management of Latex Allergy
Management focuses primarily on preventing exposure and treating reactions appropriately.
Avoidance and Prevention
People with confirmed latex allergy should learn to identify and avoid latex-containing products. Latex-free alternatives such as nitrile, vinyl, neoprene, silicone and plastic products may be used where appropriate.
Healthcare facilities should have procedures for providing a latex-safe environment, particularly for patients with a history of severe reactions.
People with a history of serious allergic reactions should also discuss an emergency action plan with their healthcare professional and may need to carry prescribed emergency medication.
Symptomatic Treatment
Treatment depends on the type and severity of the reaction. Irritant or allergic contact dermatitis may require removal of the trigger and appropriate topical treatment. Severe systemic reactions such as anaphylaxis require immediate emergency management according to established guidelines.
Latex Sublingual Immunotherapy
Latex-specific sublingual immunotherapy (SLIT) has been investigated as a potential treatment for selected patients. Studies described in the source literature have reported reductions in symptoms and latex sensitization measures, although further research is needed to establish long-term safety, effectiveness and tolerability.
Biological Treatments
Omalizumab, an anti-IgE biological treatment, has been investigated in healthcare professionals with latex allergy, including as a possible adjunct to latex immunotherapy. Evidence remains limited, and further studies are required.
Living Safely With Latex Allergy
Latex is widely used, so complete avoidance can sometimes be challenging. Patients should inform healthcare providers, dentists, schools and workplaces about their allergy and should learn which products may contain natural rubber latex.
For individuals with a history of severe reactions, medical identification and an individualized emergency plan can provide additional protection.
Conclusion
Natural rubber latex allergy can produce reactions ranging from localized skin irritation to potentially life-threatening anaphylaxis. Accurate diagnosis requires correlation of clinical history with appropriate allergy testing, including skin tests, specific IgE and, where appropriate, component-resolved diagnosis or challenge testing.
The mainstay of management is appropriate latex avoidance and prevention of accidental exposure. In selected patients, latex immunotherapy and biological treatments may have a role, although further research is needed. Evaluation by an allergy specialist is important for confirming the diagnosis and developing an appropriate management plan.










